There are 360 resources available
175P - Safety and Preliminary Efficacy of GEN1042 (DuoBody®-CD40x4-1BB) Combination Therapy in Patients With Advanced Solid Tumors
Presenter: Ignacio Melero
Session: Poster Display
69P - A Real-World Analysis of Treatment-Free survival for Advanced Melanoma Patients treated with First-Line Immune Checkpoint Inhibitors
Presenter: Mehul Gupta
Session: Poster Display
176P - Phase 1 Study of INCB106385 Alone or in Combination with Immunotherapy in Advanced Solid Tumors
Presenter: Antoine Italiano
Session: Poster Display
177P - Targeting of immune regulatory proteins through locoregional delivery of mAbs augments CD8 T cell mediated anti-tumour responses in vivo.
Presenter: Quentin Wright
Session: Poster Display
178P - Antibody engineering to evaluate binding, internalisation, and intracellular routing of recombinant immunotherapeutic fusion proteins.
Presenter: Maryam Karaan
Session: Poster Display
72P - Treatments response in non-small cell lung cancer patients according to BRCA status on liquid biopsy: a retrospective analysis
Presenter: Leonardo Provenzano
Session: Poster Display
179P - Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells (cNeT)
Presenter: Martin Forster
Session: Poster Display
73P - A randomized phase II study of neoadjuvant immunotherapy or immunochemotherapy in locally advanced oral squamous cell carcinoma
Presenter: Gang Chen
Session: Poster Display